These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33790813)

  • 1. Borderline Personality Features in Patients With Persistent Depressive Disorder and Their Effect on CBASP Outcome.
    Konvalin F; Grosse-Wentrup F; Nenov-Matt T; Fischer K; Barton BB; Goerigk S; Brakemeier EL; Musil R; Jobst A; Padberg F; Reinhard MA
    Front Psychiatry; 2021; 12():608271. PubMed ID: 33790813
    [No Abstract]   [Full Text] [Related]  

  • 2. Suicidal behaviors are associated with loneliness and decrease during inpatient CBASP treatment for persistent depressive disorder.
    Wolf J; Padberg F; Nenov-Matt T; Amann BL; Barton BB; Tang J; Glessner G; Brakemeier EL; Jobst A; Musil R; Reinhard MA
    J Psychiatr Res; 2022 Oct; 154():139-144. PubMed ID: 35939998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loneliness, Social Isolation and Their Difference: A Cross-Diagnostic Study in Persistent Depressive Disorder and Borderline Personality Disorder.
    Nenov-Matt T; Barton BB; Dewald-Kaufmann J; Goerigk S; Rek S; Zentz K; Musil R; Jobst A; Padberg F; Reinhard MA
    Front Psychiatry; 2020; 11():608476. PubMed ID: 33391058
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of Baseline Characteristics on the Effectiveness of Disorder-Specific Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and Supportive Psychotherapy in Outpatient Treatment for Persistent Depressive Disorder.
    Serbanescu I; Backenstrass M; Drost S; Weber B; Walter H; Klein JP; Zobel I; Hautzinger M; Meister R; Härter M; Schramm E; Schoepf D
    Front Psychiatry; 2020; 11():607300. PubMed ID: 33408656
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of comorbid personality disorders with clinical characteristics and outcome in a randomized controlled trial comparing two psychotherapies for early-onset persistent depressive disorder.
    Erkens N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
    J Affect Disord; 2018 Mar; 229():262-268. PubMed ID: 29329058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Behavioral Analysis System of Psychotherapy for inpatients with persistent depressive disorder: a naturalistic trial on a general acute psychiatric unit.
    Guhn A; Köhler S; Brakemeier EL; Sterzer P
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):495-505. PubMed ID: 31300878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How changes in depression severity and borderline personality disorder intensity are linked - a cohort study of depressed patients with and without borderline personality disorder.
    Söderholm JJ; Socada JL; Ekelund J; Isometsä E
    Borderline Personal Disord Emot Dysregul; 2024 Feb; 11(1):3. PubMed ID: 38369499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients.
    Assmann N; Schramm E; Kriston L; Hautzinger M; Härter M; Schweiger U; Klein JP
    Depress Anxiety; 2018 Oct; 35(10):1001-1008. PubMed ID: 30199128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating between intrapsychic symptoms and behavioral expressions of borderline personality disorder in relation to childhood emotional maltreatment and emotion dysregulation: an exploratory investigation.
    Goldbach RE; Neukel C; Panizza A; Reinken A; Krause-Utz A
    Eur J Psychotraumatol; 2023; 14(2):2263317. PubMed ID: 37846822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review.
    Potijk MR; Aan Het Rot M; Parlevliet FM; Schoevers RA; Eldering MJ
    Br J Clin Psychol; 2020 Nov; 59(4):552-564. PubMed ID: 32920864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of STEPPS in the treatment of patients with bipolar disorder and comorbid borderline personality features: a protocol for a randomized controlled trial.
    Riemann G; Weisscher N; Goossens PJ; Draijer N; Apenhorst-Hol M; Kupka RW
    BMC Psychiatry; 2014 Jun; 14():172. PubMed ID: 24912456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents.
    Ramleth RK; Groholt B; Diep LM; Walby FA; Mehlum L
    Borderline Personal Disord Emot Dysregul; 2017; 4():22. PubMed ID: 29093819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heightened subjective experience of depression in borderline personality disorder.
    Stanley B; Wilson ST
    J Pers Disord; 2006 Aug; 20(4):307-18. PubMed ID: 16901256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group interpersonal psychotherapy (IPT-G) for borderline personality disorder: A randomized controlled study.
    Bozzatello P; Blua C; Marin G; Rocca P; Bellino S
    J Psychiatr Res; 2023 Dec; 168():157-164. PubMed ID: 37913742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.
    Sabaß L; Padberg F; Normann C; Engel V; Konrad C; Helmle K; Jobst A; Worlitz A; Brakemeier EL
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):783-796. PubMed ID: 28956140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder.
    Prasko J; Brunovsky M; Latalova K; Grambal A; Raszka M; Vyskocilova J; Zavesicka L
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):355-61. PubMed ID: 21293548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood maltreatment, anxiety disorders and outcome in borderline personality disorder.
    Quenneville AF; Kalogeropoulou E; Küng AL; Hasler R; Nicastro R; Prada P; Perroud N
    Psychiatry Res; 2020 Feb; 284():112688. PubMed ID: 31784066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection sensitivity and symptom severity in patients with borderline personality disorder: effects of childhood maltreatment and self-esteem.
    Bungert M; Liebke L; Thome J; Haeussler K; Bohus M; Lis S
    Borderline Personal Disord Emot Dysregul; 2015; 2():4. PubMed ID: 26401307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological therapies for people with borderline personality disorder.
    Stoffers JM; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD005652. PubMed ID: 22895952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.